विवरण

High-content screening (HCS, also known as high-content analysis, or HCA) is an approach to cell biology that combines automated imaging and quantitative data analysis in a high-throughput format suitable for large-scale applications such as drug discovery and systems biology. Today high-content screening is established in a far broader area of the life science space as an unbiased imaging method to assess cellular function. The global high content screening market is set to grow by US$ 1.04 के दौरान अरब 2021-2027, growing at a compound annual growth rate (सीएजीआर) का 11.4% पूर्वानुमान अवधि के दौरान, डेटा और एनालिटिक्स कंपनी स्ट्रैटेजीहेलिक्स के अनुसार.

रिपोर्ट अवधि के लिए नवीनतम बाज़ार आकार डेटा प्रदान करती है 2017-2020 और पूर्वानुमान करें 2027 covering key market aspects like sales value for high content screening. The global high content screening market is segmented on the basis of product, आवेदन, end user, और क्षेत्र. उत्पाद द्वारा, it is categorized into instruments, consumables, software, and services. The instruments segment held the largest market share in 2020. By application, the high content screening market is divided into drug discovery, oncology, compound profiling, molecular diagnosis, toxicity studies, and neuroscience. Based on end user, the high content screening market is divided into pharmaceutical & biotechnology companies, शैक्षणिक, and laboratories.

The report has profiled some of the key players of the market such as Becton Dickinson and Company, Biotek Instruments Inc., दानहेर निगम (Molecular Devices LLC), Genedata AG, PerkinElmer Inc., Tecan Group Ltd., थर्मो फिशर साइंटिफिक इंक., Thorlabs Inc., Yokogawa Electric Corporation.

यह रिपोर्ट इस उद्योग में सक्रिय कंपनियों और संगठनों के लिए एक अमूल्य संसाधन है. It provides a cohesive picture of the high content screening market to help drive informed decision making for industry executives, नीति निर्माताओं, अकादमिक, और विश्लेषक.

रिपोर्ट का दायरा

उत्पाद: instruments, consumables, software, and services
आवेदन: drug discovery, oncology, compound profiling, molecular diagnosis, toxicity studies, and neuroscience
End user: pharmaceutical & biotechnology companies, शैक्षणिक, and laboratories
क्षेत्र: उत्तरी अमेरिका, एशिया प्रशांत, यूरोप, and Rest of the World (ROW)
वर्षों पर विचार किया गया: यह रिपोर्ट उस अवधि को कवर करती है 2017 को 2027

हितधारकों के लिए मुख्य लाभ

Get a comprehensive picture of the global high content screening market
Identify regional strategies and strategic priorities on the basis of local data and analysis
विकास क्षेत्रों और निवेश के रुझानों को इंगित करें
Understand what the future of the global high content screening market looks like
प्रतिस्पर्धी परिदृश्य और अवसर की खिड़की की पहचान करें

विषयसूची

1. बाज़ार परिभाषा
2. अनुसंधान क्रियाविधि
3. बाजार के आंकड़े & आउटलुक
3.1 बाजार मूल्य
3.2 बाज़ार मूल्य का पूर्वानुमान
4. High Content Screening Market by Product
4.1 Instruments
4.2 Consumables
4.3 Software
4.4 सेवाएं
5. High Content Screening Market by Application
5.1 Drug Discovery
5.2 Oncology
5.3 Compound Profiling
5.4 Molecular Diagnosis
5.5 Toxicity Studies
5.6 Neuroscience
6. High Content Screening Market by End User
6.1 Pharmaceutical & Biotechnology Companies
6.2 Academics
6.3 Laboratories
7. High Content Screening Market by Region
7.1 उत्तरी अमेरिका
7.2 एशिया प्रशांत
7.3 यूरोप
7.4 Rest Of The World (Row)
8. कंपनी प्रोफाइल
8.1 Becton, Dickinson and Company
8.2 Biotek Instruments, इंक.
8.3 दानहेर निगम (Molecular Devices, LLC)
8.4 Genedata AG
8.5 PerkinElmer, इंक.
8.6 Tecan Group Ltd.
8.7 थर्मो फिशर साइंटिफिक इंक.
8.8 Thorlabs, इंक.
8.9 Yokogawa Electric Corporation
9. अनुबंध
9.1 स्ट्रेटेजीहेलिक्स के बारे में
9.2 अस्वीकरण